<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Humana Press</PublisherName>
    <PublisherLocation>Totowa, NJ</PublisherLocation>
  </PublisherInfo>
  <Series>
    <SeriesInfo SeriesType="Series" TocLevels="0">
      <SeriesID>7651</SeriesID>
      <SeriesPrintISSN>1064-3745</SeriesPrintISSN>
      <SeriesElectronicISSN>1940-6029</SeriesElectronicISSN>
      <SeriesTitle Language="En">Methods in Molecular Biology™</SeriesTitle>
    </SeriesInfo>
    <SeriesHeader>
      <EditorGroup>
        <Editor AffiliationIDS="Aff1">
          <EditorName DisplayOrder="Western">
            <GivenName>J.M.</GivenName>
            <FamilyName>Walker</FamilyName>
          </EditorName>
        </Editor>
        <Affiliation ID="Aff1">
          <OrgName>School of Life Sciences University of Hertfordshire</OrgName>
          <OrgAddress>
            <City>Hatfield</City>
            <State>Hertfordshire, AL10 9AB</State>
            <Country>UK</Country>
          </OrgAddress>
        </Affiliation>
      </EditorGroup>
    </SeriesHeader>
    <Book Language="En">
      <BookInfo BookProductType="Contributed volume" ContainsESM="No" Language="En" MediaType="eBook" NumberingStyle="ChapterContentSeparately" OutputMedium="Online" TocLevels="0">
        <BookID>978-1-60327-527-9</BookID>
        <BookTitle>T Cell Protocols</BookTitle>
        <BookSubTitle>Second Edition</BookSubTitle>
        <BookVolumeNumber>514</BookVolumeNumber>
        <BookSequenceNumber>514</BookSequenceNumber>
        <BookDOI>10.1007/978-1-60327-527-9</BookDOI>
        <BookTitleID>145011</BookTitleID>
        <BookPrintISBN>978-1-58829-587-3</BookPrintISBN>
        <BookElectronicISBN>978-1-60327-527-9</BookElectronicISBN>
        <BookChapterCount>11</BookChapterCount>
        <BookCopyright>
          <CopyrightHolderName>Humana Press</CopyrightHolderName>
          <CopyrightYear>2009</CopyrightYear>
        </BookCopyright>
        <BookSubjectGroup>
          <BookSubject Code="SCL" Type="Primary">Life Sciences</BookSubject>
          <BookSubject Code="SCL14005" Priority="1" Type="Secondary">Biochemistry, general</BookSubject>
          <BookSubject Code="SCB14000" Priority="2" Type="Secondary">Immunology</BookSubject>
          <BookSubject Code="SCL16020" Priority="3" Type="Secondary">Cell Culture</BookSubject>
          <SubjectCollection Code="SUCO11642">Biomedical and Life Sciences</SubjectCollection>
        </BookSubjectGroup>
        <BookContext>
          <SeriesID>7651</SeriesID>
        </BookContext>
      </BookInfo>
      <BookHeader>
        <EditorGroup>
          <Editor AffiliationIDS="Aff2">
            <EditorName DisplayOrder="Western">
              <GivenName>Gennaro</GivenName>
              <Particle>De</Particle>
              <FamilyName>Libero</FamilyName>
            </EditorName>
            <Role>Dr</Role>
            <Contact>
              <Email>Gennaro.DeLibero@unibas.ch</Email>
            </Contact>
          </Editor>
          <Affiliation ID="Aff2">
            <OrgName>University of Basel</OrgName>
            <OrgAddress>
              <State>Basel</State>
              <Country>Switzerland</Country>
            </OrgAddress>
          </Affiliation>
        </EditorGroup>
      </BookHeader>
      <Chapter ID="Chap10" Language="En">
        <ChapterInfo ChapterType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="ChapterContentSeparately" OutputMedium="Online" TocLevels="0">
          <ChapterID>10</ChapterID>
          <ChapterNumber>Chapter 10</ChapterNumber>
          <ChapterDOI>10.1007/978-1-60327-527-9_10</ChapterDOI>
          <ChapterSequenceNumber>10</ChapterSequenceNumber>
          <ChapterTitle Language="En">Purification of the T Cell Antigen Receptor and Analysis by Blue-Native PAGE</ChapterTitle>
          <ChapterFirstPage>135</ChapterFirstPage>
          <ChapterLastPage>150</ChapterLastPage>
          <ChapterCopyright>
            <CopyrightHolderName>Humana Press, a part of Springer Science+Business Media, LLC</CopyrightHolderName>
            <CopyrightYear>2009</CopyrightYear>
          </ChapterCopyright>
          <ChapterGrants Type="Regular">
            <MetadataGrant Grant="OpenAccess"/>
            <AbstractGrant Grant="OpenAccess"/>
            <BodyPDFGrant Grant="Restricted"/>
            <BodyHTMLGrant Grant="Restricted"/>
            <BibliographyGrant Grant="Restricted"/>
            <ESMGrant Grant="Restricted"/>
          </ChapterGrants>
          <ChapterContext>
            <SeriesID>7651</SeriesID>
            <BookID>978-1-60327-527-9</BookID>
            <BookTitle>T Cell Protocols</BookTitle>
          </ChapterContext>
        </ChapterInfo>
        <ChapterHeader>
          <AuthorGroup>
            <Author AffiliationIDS="Aff3" CorrespondingAffiliationID="Aff3">
              <AuthorName DisplayOrder="Western">
                <GivenName>Mahima</GivenName>
                <FamilyName>Swamy</FamilyName>
              </AuthorName>
            </Author>
            <Author AffiliationIDS="Aff3">
              <AuthorName DisplayOrder="Western">
                <GivenName>Wolfgang</GivenName>
                <GivenName>W.A.</GivenName>
                <FamilyName>Schamel</FamilyName>
              </AuthorName>
              <Role>PhD</Role>
            </Author>
            <Affiliation ID="Aff3">
              <OrgDivision>Department of Molecular Immunology, Max Planck Institute for Immunobiology</OrgDivision>
              <OrgName>University of Freiburg</OrgName>
              <OrgAddress>
                <State>Freiburg</State>
                <Country>Germany</Country>
              </OrgAddress>
            </Affiliation>
          </AuthorGroup>
          <Abstract ID="Abs1" Language="En">
            <Heading>Abstract</Heading>
            <Para TextBreak="No">The T cell antigen receptor (TCR) is a multi-protein complex composed of six different transmembrane subunits, which form complexes of various sizes on the surface of resting T cells. The stoichiometry of the smallest form was recently determined to be αβγεδεζζ, whereas that of the larger forms is unknown. The roles of the different forms and their ratios are poorly defined. Biochemical analyses to address these questions must focus on the detergent and the best native conditions to maintain the integrity of the complexes. Blue-native polyacrylamide gel electrophoresis (BN-PAGE) is a high-resolution native protein separation method that relies on the dye Coomassie blue to confer negative charge for separation. Using this powerful approach, the size, subunit composition and the relative abundance of the different TCR forms can be studied. We present here four methods to isolate the TCR in a native form and details to analyse it by BN-PAGE.</Para>
          </Abstract>
          <KeywordGroup Language="En">
            <Heading>Key words</Heading>
            <Keyword>T cells</Keyword>
            <Keyword>T cell receptor</Keyword>
            <Keyword>BN-PAGE</Keyword>
            <Keyword>multi-protein complex</Keyword>
            <Keyword>stoichiometry</Keyword>
            <Keyword>affinity purification</Keyword>
          </KeywordGroup>
        </ChapterHeader>
        <Body>
          <Section1 ID="Sec1" OutputMedium="Online" Type="Introduction">
            <Heading>Introduction</Heading>
            <Para TextBreak="No">Mature T cells specifically recognize antigenic peptide-major histocompatibility complex (pMHC) complexes through their T cell antigen receptors (TCR). This recognition event leads to activation of the T cells, and the triggering of an immune response. Since soluble pMHC complexes must be at least dimeric in order to activate the TCR <CitationRef CitationID="CR1">(1</CitationRef>, <CitationRef CitationID="CR2">2)</CitationRef>, it has been widely proposed that two TCRs must be brought together by multimeric pMHC, in order for the TCR to get activated (clustering model). This model requires that the TCR be monomeric before activation. The conformational change model, where pMHC induces a conformational change in the cytoplasmic tails of the TCR <CitationRef CitationID="CR3">(3</CitationRef>, <CitationRef CitationID="CR4">4)</CitationRef>, or the segregation model <CitationRef CitationID="CR5">(5)</CitationRef>, where activated TCRs are segregated from phosphatases and inactivating influences, are indifferent to the multimerization status of the TCR. Hence, a method that can clearly define the stoichiometry and structure of the TCR on the cell surface would be very beneficial for further studies on the receptor.</Para>
            <Para TextBreak="No">Biochemical studies that analysed the structure of the TCR on the cell membrane have often reached conflicting conclusions due to the complex nature of this transmembrane receptor (for example, see <Emphasis Type="Italic">6, 7</Emphasis>). The TCR is composed of eight transmembrane chains: the antigen-binding variable TCRαβ heterodimer and the invariant CD3εγ, CD3εδ, and TCRζ<Subscript>2</Subscript> (CD247<Subscript>2</Subscript>) dimers (<Emphasis Type="Bold">Fig.</Emphasis>
              <InternalRef RefID="Fig10_1_978-1-60327-527-9">
                <Emphasis Type="Bold">10.1</Emphasis>
              </InternalRef>
              <Emphasis Type="Bold">a</Emphasis>). These dimers are non-covalently associated with each other in the context of the membrane. The invariant subunits each have an intracellular signalling-competent tail, with which they transmit the information of ligand-binding to the cytosolic signalling proteins. Receptor activation through the TCRαβ subunits needs to be transmitted to the CD3 and TCRζ chains in spite of the weak associations. Thus, biochemical analysis of the TCR must be focused on maintaining these interactions, and maintaining the receptor in its most native conformation.
<Figure Category="Standard" Float="Yes" ID="Fig10_1_978-1-60327-527-9">
                <Caption Language="En">
                  <CaptionNumber>Fig. 10.1.</CaptionNumber>
                  <CaptionContent>
                    <SimplePara>Isolation of the TCR using anti-phosphotyrosine antibodies and analysis by BN-PAGE.</SimplePara>
                    <SimplePara>(<Emphasis Type="Bold">a</Emphasis>) Scheme for preparation of the TCR using anti-phosphotyrosine antibodies for immunoprecipitation and phenyl phosphate for elution. <Emphasis Type="Italic">Black circles</Emphasis> on the TCR indicate the sites of ITAM phosphorylation. (<Emphasis Type="Bold">b</Emphasis>) and (<Emphasis Type="Bold">c</Emphasis>) Pervanadate-treated cells, either Jurkat (human) or 2B4 (mouse) T cell lines, were lysed in either 0.5% Brij96, 1% digitonin or 1% DDM. After anti-phosphotyrosine immunoprecipitation and elution with 10 mM phenyl phosphate, the eluates were separated on BN gels. After the gel run, the proteins were transferred to PVDF membranes, and immunoblotted with an anti-TCRζ serum. (<Emphasis Type="Bold">b</Emphasis>) The TCR was detected in its monovalent (smaller) and multivalent (larger) complexes when purified using the detergent Brij (lanes 1 and 3), whereas all TCR is broken down to the monovalent form by the detergent digitonin (lanes 2 and 4). (<Emphasis Type="Bold">c</Emphasis>) The detergent DDM also breaks down all TCRs to the monovalent form (lanes 2 and 4). The bands of the marker protein ferritin in its 24-meric (f1) and 48-meric (f2) forms are indicated on the <Emphasis Type="Italic">left</Emphasis> of each panel.</SimplePara>
                  </CaptionContent>
                </Caption>
                <MediaObject>
                  <ImageObject Color="BlackWhite" FileRef="MediaObjects/978-1-60327-527-9_10_Fig1_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Linedraw"/>
                </MediaObject>
              </Figure>
            </Para>
            <Para TextBreak="No">A high-resolution method for the characterization of native protein complexes is blue-native polyacrylamide gel electrophoresis (BN-PAGE) <CitationRef CitationID="CR8">(8</CitationRef>–<CitationRef CitationID="CR11">11)</CitationRef>. This technique makes use of the fact that the dye Coomassie Blue binds non-specifically to all proteins does not denature the proteins and is negatively charged. When this dye is added to the sample before electrophoresis, the protein complexes are separated based on the size of the complex (plus detergent/lipid micelle), and the negative charge of the bound Coomassie Blue.</Para>
            <Para TextBreak="No">When applied to the TCR, BN-PAGE analysis showed that the TCR was found in variously sized complexes, depending on the detergent used (<Emphasis Type="Bold">Figs.</Emphasis>
              <InternalRef RefID="Fig10_1_978-1-60327-527-9">
                <Emphasis Type="Bold">10.1</Emphasis>
              </InternalRef>–<InternalRef RefID="Fig10_4_978-1-60327-527-9">
                <Emphasis Type="Bold">10.4</Emphasis>
              </InternalRef>) <CitationRef CitationID="CR12">(12</CitationRef>, <CitationRef CitationID="CR13">13)</CitationRef>. On further experimentation, we realized that the TCR exists in a minimal αβγεδεζζ complex, and also in larger complexes, which were either maintained, or broken down to the minimal complex, depending on which detergent was used. Large TCR complexes were also detected by electron microscopy of immunogold-labelled TCRs on fixed T cell membranes. Thus, the TCR exists in larger clusters with more than one TCRαβ before ligand-binding. Additionally, the ratio between large and small complexes varies from cell to cell. Several studies did not detect the TCR multimers, since they used detergents that disrupt these complexes; reviewed in <Emphasis Type="Bold">Ref.</Emphasis>
              <CitationRef CitationID="CR13">(13)</CitationRef>. Thus, we would like to stress that the choice of detergent for TCR analysis must be carefully thought over.
<Figure Category="Standard" Float="Yes" ID="Fig10_2_978-1-60327-527-9">
                <Caption Language="En">
                  <CaptionNumber>Fig. 10.2.</CaptionNumber>
                  <CaptionContent>
                    <SimplePara>Preparation of total cellular membranes and BN-PAGE analysis of the TCR.</SimplePara>
                    <SimplePara>(<Emphasis Type="Bold">a</Emphasis>) Flow chart of the membrane preparation procedure. (<Emphasis Type="Bold">b</Emphasis>) Immunoblotting of the TCR in membrane preparations separated by BN-PAGE. Membranes were prepared by homogenizing unstimulated human peripheral blood lymphocytes. After ultracentrifugation, the membrane pellet was lysed in 0.5% Brij96, and analysed by BN-PAGE (lane 1). As in <Emphasis Type="Bold">Fig.</Emphasis>
                      <InternalRef RefID="Fig10_1_978-1-60327-527-9">
                        <Emphasis Type="Bold">10.1</Emphasis>
                      </InternalRef>, multivalent and monovalent complexes were detected. Membrane preparations of the human T cell line Jurkat were lysed in either 0.5% Brij96 (lane 2) or 1% digitonin (lane 3), separated by BN-PAGE, and then immunoblotted with an anti-TCRζ serum. Again, digitonin disrupted the multivalent TCRs. The ferritin marker bands are indicated to the <Emphasis Type="Italic">left</Emphasis> (f1 and f2).</SimplePara>
                  </CaptionContent>
                </Caption>
                <MediaObject>
                  <ImageObject Color="BlackWhite" FileRef="MediaObjects/978-1-60327-527-9_10_Fig2_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Linedraw"/>
                </MediaObject>
              </Figure>
              <Figure Category="Standard" Float="Yes" ID="Fig10_3_978-1-60327-527-9">
                <Caption Language="En">
                  <CaptionNumber>Fig. 10.3.</CaptionNumber>
                  <CaptionContent>
                    <SimplePara>One-step purification of the SBP-tagged TCR and analysis by BN-PAGE.</SimplePara>
                    <SimplePara>(<Emphasis Type="Bold">a</Emphasis>) ζ-SBP containing TCR and the scheme for its purification procedure. (<Emphasis Type="Bold">b</Emphasis>) BN-PAGE analysis of the ζ-SBP TCR. Mζ-SBP murine T cells were lysed in either 0.5% Brij96 (lane 1), 1% digitonin (lane 2), or 1% DDM (lane 3) and the ζ-SBP TCR was precipitated using streptavidin–sepharose. After elution using 2 mM biotin, the TCRs were resolved by BN-PAGE. Immunoblotting was performed with an anti-ζ serum. (<Emphasis Type="Bold">c</Emphasis>) High yield and purity are obtained using the ζ-SBP TCR. The digitonin-extracted TCR from Mζ-SBP cells was purified using streptavidin–sepharose and biotin elution, and then separated by BN-PAGE. The lane was cut out, incubated in Laemmli buffer and subjected to a second dimension SDS-PAGE. The second dimension gel was then silver-stained as per standard protocols. The subunits corresponding to the spots on the gel are indicated to the <Emphasis Type="Italic">right</Emphasis>. The sizes of the marker protein bands are indicated to the <Emphasis Type="Italic">left</Emphasis>, in kilo Daltons.</SimplePara>
                  </CaptionContent>
                </Caption>
                <MediaObject>
                  <ImageObject Color="BlackWhite" FileRef="MediaObjects/978-1-60327-527-9_10_Fig3_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Linedraw"/>
                </MediaObject>
              </Figure>
              <Figure Category="Standard" Float="Yes" ID="Fig10_4_978-1-60327-527-9">
                <Caption Language="En">
                  <CaptionNumber>Fig. 10.4.</CaptionNumber>
                  <CaptionContent>
                    <SimplePara>One step purification of the sc-tagged TCR and analysis by BN-PAGE.</SimplePara>
                    <SimplePara>(<Emphasis Type="Bold">a</Emphasis>) A schematic representation of the scTCR and the procedure for its purification are shown. (<Emphasis Type="Bold">b</Emphasis>) BN-PAGE analysis of the digitonin- (lane 1) and Brij96- (lane 2) extracted scTCR. 31.13scTCRβ cells were lysed in 1% digitonin or 0.5% Brij96 and the scTCR was affinity purified by NP-sepharose beads. The TCR was then eluted using 5 mM free NIP-CAP. After separation by BN-PAGE, immunoblotting was performed with an anti-TCRζ serum, as in previous figures.</SimplePara>
                  </CaptionContent>
                </Caption>
                <MediaObject>
                  <ImageObject Color="BlackWhite" FileRef="MediaObjects/978-1-60327-527-9_10_Fig4_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Linedraw"/>
                </MediaObject>
              </Figure>
            </Para>
            <Para TextBreak="No">The existence of large TCR complexes containing up to ten TCRαβ indicates that the clustering model of TCR activation becomes rather unlikely. New models must then be developed for the mechanism of T cell activation. We have recently suggested that TCR triggering requires two events simultaneously: TCR clustering (either induced by multimeric ligand-binding or present before ligand-binding) and a conformational change at CD3 (induced by multimeric ligand-binding) <CitationRef CitationID="CR4">(4)</CitationRef>. In addition, the existence of multivalent TCR clusters also has an impact on the sensitivity of T cells to antigen, as these clusters would have an increased avidity for multimeric pMHC complexes <CitationRef CitationID="CR13">(13)</CitationRef>.</Para>
            <Para TextBreak="No">We describe here the various isolation techniques that are used to obtain the TCR complex in a native state and the method for pouring and running BN-PAGE. The first technique involves immunoprecipitating the phosphorylated TCR and then eluting it from anti-phosphotyrosine beads using phenyl phosphate. This is our most preferred method of purification, due to ease of application, and the possibility to apply it to all cell types. For this method the TCR has to be phosphorylated. The second method, which is also universally applicable, is to prepare total cellular membranes. The last two methods describe the purification of the TCR through affinity-based tags. These methods have the caveat that they require cell lines expressing the tagged subunit of the TCR, but they do provide efficient and pure preparations of the TCR.</Para>
          </Section1>
          <Section1 ID="Sec2" OutputMedium="Online">
            <Heading>Materials</Heading>
            <Section2 ID="Sec3" OutputMedium="Online">
              <Heading>Isolation of the TCR Using Anti-Phosphotyrosine Antibodies</Heading>
              <Para TextBreak="No">All buffers have to be prepared with distilled/deionized water (dH<Subscript>2</Subscript>O).<OrderedList>
                  <ListItem>
                    <ItemNumber>1.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Pervanadate (100×): 5 μl 50 mM sodium orthovanadate, 5.7 μl dH<Subscript>2</Subscript>O, 1.5 μl 30% H<Subscript>2</Subscript>O<Subscript>2</Subscript>. Mix in this order; incubate 5–30 min at room temperature before use. Due to oxidation the vanadate becomes brownish.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>2.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Sepharose or agarose beads coupled to anti-phosphotyrosine antibodies (for example, the antibody 4G10, Upstate Biotech, UK).</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>3.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Phenyl phosphate (prepare a 1 M stock in dH<Subscript>2</Subscript>O just before use).</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>4.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Alkaline phosphatase (e.g. from New England Biolabs).</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>5.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Detergents:<OrderedList>
                          <ListItem>
                            <ItemNumber>a.</ItemNumber>
                            <ItemContent>
                              <Para TextBreak="No">Digitonin: 2% w/v stock solution in dH<Subscript>2</Subscript>O. Freeze aliquots at −20°C. Thawed solutions are stable at room temperature for up to a week. If a precipitate forms, reheat the solution to 95°C until the digitonin redissolves.</Para>
                            </ItemContent>
                          </ListItem>
                          <ListItem>
                            <ItemNumber>b.</ItemNumber>
                            <ItemContent>
                              <Para TextBreak="No">Brij 96: 10% w/v stock solution in dH<Subscript>2</Subscript>O. Store at room temperature.</Para>
                            </ItemContent>
                          </ListItem>
                          <ListItem>
                            <ItemNumber>c.</ItemNumber>
                            <ItemContent>
                              <Para TextBreak="No">Dodecylmaltoside (DDM): 10% w/v stock solution in dH<Subscript>2</Subscript>O. Store aliquots at 4°C.</Para>
                            </ItemContent>
                          </ListItem>
                        </OrderedList>
                      </Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>6.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Protease and phosphatase inhibitor stock solutions (toxic):<OrderedList>
                          <ListItem>
                            <ItemNumber>a.</ItemNumber>
                            <ItemContent>
                              <Para TextBreak="No">Leupeptin (1,000×): Prepare a 10 mg/ml solution in dH<Subscript>2</Subscript>O. Store 1 ml aliquots at 20°C.</Para>
                            </ItemContent>
                          </ListItem>
                          <ListItem>
                            <ItemNumber>b.</ItemNumber>
                            <ItemContent>
                              <Para TextBreak="No">Aprotinin (1,000×): Prepare a 10 mg/ml solution in dH<Subscript>2</Subscript>O. Store 1 ml aliquots at 20°C.</Para>
                            </ItemContent>
                          </ListItem>
                          <ListItem>
                            <ItemNumber>c.</ItemNumber>
                            <ItemContent>
                              <Para TextBreak="No">PMSF (100×): Prepare a 100 mM solution in ethanol. Store 1 ml aliquots at 20°C.</Para>
                            </ItemContent>
                          </ListItem>
                          <ListItem>
                            <ItemNumber>d.</ItemNumber>
                            <ItemContent>
                              <Para TextBreak="No">Sodium orthovanadate (100×): Prepare a 50 mM solution in dH<Subscript>2</Subscript>O. Store at room temperature.</Para>
                            </ItemContent>
                          </ListItem>
                          <ListItem>
                            <ItemNumber>e.</ItemNumber>
                            <ItemContent>
                              <Para TextBreak="No">Sodium fluoride (100×): Prepare a 1 M solution in dH<Subscript>2</Subscript>O. Store at room temperature.</Para>
                            </ItemContent>
                          </ListItem>
                        </OrderedList>
                      </Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>7.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Lysis buffer (1×)<Emphasis Type="Bold">:</Emphasis> 20 mM Tris–HCl, pH 7.4, 137 mM NaCl, 2 mM EDTA pH 8.0, 10% glycerol. Prepare a 2× stock and store at 4°C. Add detergent of interest (end concentration: 1% digitonin or 0.5% Brij 96 or 1% DDM) and protease and phosphatase inhibitors just before use, at 1× concentration.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>8.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">BN lysis buffer (1×): 20 mM Bis–tris pH 7.0, adjusted with HCl, 500 mM 6-aminohexanoic acid, 20 mM NaCl, 2 mM EDTA pH 8.0, 10% glycerol. Prepare a 2× stock and store at 4°C. Add detergent of interest and protease and phosphatase inhibitors as for lysis buffer. Upon addition of sodium orthovanadate the buffer will get a yellowish colour.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>9.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">BN wash buffer (1×): Same as BN lysis buffer, but the amount of detergent is reduced to half. Add protease inhibitors and omit phosphatase inhibitors.</Para>
                    </ItemContent>
                  </ListItem>
                </OrderedList>
              </Para>
            </Section2>
            <Section2 ID="Sec4" OutputMedium="Online">
              <Heading>Preparation of Total Membrane Fractions</Heading>
              <Para TextBreak="No">
                <OrderedList>
                  <ListItem>
                    <ItemNumber>1.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Hypotonic lysis buffer: 10 mM HEPES, pH 7.4, 42 mM KCl, 5 mM MgCl<Subscript>2</Subscript>. Store at 4°C. Add protease inhibitors just before use.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>2.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Dounce homogenizer.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>3.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Ultracentrifuge (e.g. from Beckman TLA100).</Para>
                    </ItemContent>
                  </ListItem>
                </OrderedList>
              </Para>
            </Section2>
            <Section2 ID="Sec5" OutputMedium="Online">
              <Heading>Purification of the TCR Through Tagged Subunits of the Receptor</Heading>
              <Para TextBreak="No">
                <OrderedList>
                  <ListItem>
                    <ItemNumber>1.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">The streptavidin-binding-peptide (SBP) is a 38-amino acid sequence that can be utilized to purify attached proteins due to its high affinity (<Emphasis Type="Italic">K</Emphasis>
                        <Subscript>D</Subscript>=2.5 nM) to streptavidin-coupled beads <CitationRef CitationID="CR14">(14)</CitationRef>. The plasmid encoding TCRζ-SBP was generated by ligating the sequence of SBP to the 3’end of the coding sequence of the murine TCRζ chain through a flexible linker. Upon transfection of this DNA into the murine TCRζ-deficient cell line MA5.8, a TCR-SBP (<Emphasis Type="Bold">Fig.</Emphasis>
                        <InternalRef RefID="Fig10_3_978-1-60327-527-9">
                          <Emphasis Type="Bold">10.3a</Emphasis>
                        </InternalRef>) expressing clone was obtained (Mζ-SBP).</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>2.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Streptavidin-coupled agarose beads (for example, UltraLink Immobilized Streptavidin Plus Gel, Pierce Biotechnology, USA).</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>3.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Biotin, 40 mM stock solution in 0.02 N NaOH. Store at 4°C.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>4.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">The expression vector for the single chain-tagged TCRβ (scTCRβ) was generated by fusing the sequence for the single chain Fv fragment of an anti-NIP antibody to the sequence of the human Vβ HA1.7 chain. The cell line 31–13.scTCRβ was generated by transfecting an expression vector encoding for the scTCRβ protein into the TCRβ-deficient mutant 31–13 <CitationRef CitationID="CR4">(4)</CitationRef>, which is derived from the human T cell line Jurkat. The sc-tag was introduced C-terminal of the signal sequence cleavage site.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>5.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">NP (4-hydroxy-3-nitrophenylacetyl) sepharose beads (Biosearch Technologies).</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>6.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">NIP-CAP (4-hydroxy-3-iodo-5-nitrophenylacetic caproic acid, Biosearch Technologies), 500 mM stock solution in DMSO. Store at room temperature.</Para>
                    </ItemContent>
                  </ListItem>
                </OrderedList>
              </Para>
            </Section2>
            <Section2 ID="Sec6" OutputMedium="Online">
              <Heading>Pouring and Running of the BN-PAGE</Heading>
              <Para TextBreak="No">
                <OrderedList>
                  <ListItem>
                    <ItemNumber>1.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Acrylamide:bisacrylamide solution in the ratio 32:1, %T=41.25, %C=3 (<Emphasis Type="Italic">see</Emphasis>
                        <Emphasis Type="Bold">Note 1</Emphasis>). Acrylamide is a potent neurotoxin, so suitable precautions must be taken while handling.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>2.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Bis–tris (e.g. from Roth).</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>3.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Tricine.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>4.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">6-Aminohexanoic acid (also known as ε-aminocaproic acid).</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>5.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Coomassie Blue G250 (Serva).</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>6.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Gradient mixer (e.g. from Bio-Rad).</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>7.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Silicon tubing, 3–5 mm diameter, 1 m length.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>8.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Peristaltic pump (e.g. from Amersham Pharmacia Biotech).</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>9.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Gel electrophoresis system (e.g. Bio-Rad Protean II or III, <Emphasis Type="Italic">see</Emphasis>
                        <Emphasis Type="Bold">Note 2</Emphasis>).</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>10.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Semi-dry transfer equipment.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>11.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Polyvinylidene difluoride (PVDF) membrane (e.g. from Immobilon P, Millipore).</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>12.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">SDS-PAGE gel running system and buffers.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>13.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Silver staining and/or Coomassie staining reagents.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>14.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Anti-TCR antibody for immunoblotting (<Emphasis Type="Italic">see</Emphasis>
                        <Emphasis Type="Bold">Note 3</Emphasis>).</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>15.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">BN-gel buffer (3×): 150 mM Bis–tris pH 7.0, adjusted with HCl, 200 mM 6-aminohexanoic acid. Store at 4°C.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>16.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Low percentage separating gel, 4% (adjust volumes as per requirements): 1.5 ml acrylamide:bisacrylamide solution, 5 ml BN-gel buffer (33×), 8.5 ml dH<Subscript>2</Subscript>O, 54 μl APS (ammonium persulfate, 10% w/v in dH<Subscript>2</Subscript>O), 5.4 μl TEMED.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>17.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">High-percentage separating gel, 9% (adjust volumes as per requirements): 3.38 ml acrylamide:bisacrylamide solution, 5 ml BN-gel buffer (3×), 6.63 ml glycerol 70%, 42 μl APS (ammonium persulfate), 42 μl TEMED.</Para>
                      <Para TextBreak="No">Note that the combined volumes of the two solutions (low- and high- percentage separating gels) should be exactly equal to the volume required to fill the space between the glass plates to the required height.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>18.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Stacking gel, 3.2% (adjust volumes as per requirements): 0.72 ml acrylamide:bisacrylamide solution, 3 ml BN-gel buffer (3×), 5.28 ml dH<Subscript>2</Subscript>O, 120 μl APS (ammonium persulfate), 12 μl TEMED.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>19.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Anode buffer: 50 mM Bis–tris pH 7.0, adjusted with HCl. Prepare a 10× stock and store at room temperature. Buffer (1×) should be pre-chilled for use.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>20.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Cathode buffer: 15 mM Bis–tris pH 7.0, adjusted with HCl, 50 mM Tricine, 0.02% Coomassie Blue G250. Prepare a 10× stock and store at room temperature. Buffer (1×) should be pre-chilled for use.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>21.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Marker protein mix: 10 mg/ml aldolase (158 kD), 10 mg/ml catalase (232 kD), 10 mg/ml ferritin (440 and 880 kD), 10 mg/ml thyroglobulin (670 kD), 10 mg/ml BSA (66 and 132 kD). Prepare in BN lysis buffer without detergent or inhibitors (<Emphasis Type="Italic">see</Emphasis>
                        <Emphasis Type="Bold">Note 4</Emphasis>). Store at 4°C.</Para>
                    </ItemContent>
                  </ListItem>
                </OrderedList>
              </Para>
            </Section2>
          </Section1>
          <Section1 ID="Sec7" OutputMedium="Online">
            <Heading>Methods</Heading>
            <Section2 ID="Sec8" OutputMedium="Online">
              <Heading>Isolation of the TCR Using Anti-Phosphotyrosine Antibodies</Heading>
              <Para TextBreak="No">Pervanadate, generated by mixing vanadate and H<Subscript>2</Subscript>O<Subscript>2</Subscript>, is a tyrosine phosphatase inhibitor, and can thus be employed to induce maximal phosphorylation of the TCR. This phosphorylation by pervanadate does not change the stoichiometry of the receptor, nor does it affect the multimerization status. On the other hand, it provides a convenient method to isolate the TCR, as the TCR has at least 20 tyrosine phosphorylation sites in the immunoreceptor tyrosine-based activation motifs (ITAMs) (<Emphasis Type="Bold">Fig.</Emphasis>
                <InternalRef RefID="Fig10_1_978-1-60327-527-9">
                  <Emphasis Type="Bold">10.1a</Emphasis>
                </InternalRef>), and can be immunoprecipitated with anti-phosphotyrosine antibodies. Subsequently, the TCR can be eluted from the beads using phenyl phosphate and then dephosphorylated using alkaline phosphatase. While this is the most convenient technique for the enrichment of the native TCR, it has the disadvantage that other phosphoproteins are also purified. This procedure can also be used for T cells stimulated by other methods that also induce phosphorylation of the TCR, for example, stimulation by pMHC.<OrderedList>
                  <ListItem>
                    <ItemNumber>1.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Harvest 30 × 10<Superscript>6</Superscript> T cells and resuspend in 1 ml serum-free medium.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>2.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Equilibrate to 5% CO<Subscript>2</Subscript>, 37°C, for 10 min, and then stimulate with 10 µl pervanadate for 5 min.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>3.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Pellet the cells briefly (1,000 <Emphasis Type="Italic">g</Emphasis>), and resuspend in 1 ml lysis buffer containing the appropriate detergent at 4°C.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>4.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Lyse the cells for 15 min on ice, and then centrifuge the lysate at 12,000 <Emphasis Type="Italic">g</Emphasis> for 15 min at 4°C.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>5.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Add 3–10 µl of anti-phosphotyrosine beads to the clarified supernatant.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>6.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Incubate the clarified supernatant with the beads for at least 4 h by rotating at 4°C.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>7.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Pellet the beads briefly (1,000 <Emphasis Type="Italic">g</Emphasis>), and wash the beads three times with BN wash buffer containing the same detergent as the lysis buffer.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>8.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Prepare the elution buffer from the BN wash buffer, by adding 100 mM phenyl phosphate to it.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>9.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Elute the TCR (along with other phosphorylated proteins) from the beads at 4°C, by resuspending the beads in 20–100 µl of BN elution buffer.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>10.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Incubate the beads in the elution buffer for 30 min at 4°C, resuspending occasionally (<Emphasis Type="Italic">see</Emphasis>
                        <Emphasis Type="Bold">Note 6</Emphasis>).</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>11.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">To dephosphorylate the TCR, 1–2 units of alkaline phosphatase can be added during the last 5 min of the incubation.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>12.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Pellet the beads briefly, and remove the supernatant to a new tube.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>13.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">The TCR-containing eluate can now be separated by BN-PAGE.</Para>
                    </ItemContent>
                  </ListItem>
                </OrderedList>
              </Para>
            </Section2>
            <Section2 ID="Sec9" OutputMedium="Online">
              <Heading>Preparation of Total Membranes for Analysis of the TCR</Heading>
              <Para TextBreak="No">In certain experiments pervanadate stimulation of the TCR is not desirable. In these cases, total membrane preparations can be made for analysis by BN-PAGE, which has the additional advantage that the yield is high. Briefly, the cells are allowed to swell in a hypotonic buffer, and then broken by mechanical shearing. The resultant membrane patches are pelleted in an ultracentrifuge, and then lysed in the BN buffer (<Emphasis Type="Bold">Fig.</Emphasis>
                <InternalRef RefID="Fig10_2_978-1-60327-527-9">
                  <Emphasis Type="Bold">10.2</Emphasis>
                </InternalRef>). Since this method does not separate the plasma membrane from other membranes of the cell, internalized TCRs, and partially assembled TCRs are also isolated. Also, as with purifications using anti-phosphotyrosine antibodies, other proteins are purified along with the TCR.<OrderedList>
                  <ListItem>
                    <ItemNumber>1.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Wash 5–15 × 10<Superscript>6</Superscript> T cells in cold PBS, and resuspend in 1 ml hypotonic lysis buffer.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>2.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Allow the cells to swell for 10 min on ice and then break the cells by mechanical shearing in a Dounce homogenizer, 10–15 strokes, for a total of 3 min.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>3.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Centrifuge the homogenate for 10 min at 150 <Emphasis Type="Italic">g</Emphasis> at 4°C to get rid of whole cells and nuclei.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>4.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Pellet the membrane patches containing the TCR by centrifuging the supernatant at 100,000 <Emphasis Type="Italic">g</Emphasis> for 30 min in an ultracentrifuge at 4°C.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>5.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">If cytoplasmic contaminants are to be stringently removed, wash the membrane pellet once in hypotonic lysis buffer, and centrifuge at 100,000 <Emphasis Type="Italic">g</Emphasis> for 10 min.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>6.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Resuspend the membrane pellet carefully, in 250 µl BN lysis buffer containing the appropriate detergent at 4°C. Incubate for 45 min to 1 h, periodically resuspending with a pipette, to ensure that the membranes are completely dissolved.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>7.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Centrifuge this membrane lysate in an ultracentrifuge for 10 min at 100,000 <Emphasis Type="Italic">g</Emphasis> at 4°C (<Emphasis Type="Italic">see</Emphasis>
                        <Emphasis Type="Bold">Note 5</Emphasis>).</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>8.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">The supernatant is the TCR-containing membrane lysate that can be separated by BN-PAGE.</Para>
                    </ItemContent>
                  </ListItem>
                </OrderedList>
              </Para>
            </Section2>
            <Section2 ID="Sec10" OutputMedium="Online">
              <Heading>Purification of the TCR Through Tagged Subunits of the Receptor</Heading>
              <Para TextBreak="No">If a very pure preparation of the TCR is needed for analysis by BN-PAGE, the best method is to purify a tagged version of the receptor. We have used two different tags; the streptavidin-binding peptide (SBP) <CitationRef CitationID="CR14">(14)</CitationRef> fused to the C-terminus of the TCRζ chain (ζ-SBP, <Emphasis Type="Bold">Fig.</Emphasis>
                <InternalRef RefID="Fig10_3_978-1-60327-527-9">
                  <Emphasis Type="Bold">10.3a</Emphasis>
                </InternalRef>), and a single chain variable fragment Fv (sc) of an anti-NIP antibody <CitationRef CitationID="CR15">(15)</CitationRef> attached to the N-terminus of TCRβ (scTCRβ, <Emphasis Type="Bold">Fig.</Emphasis>
                <InternalRef RefID="Fig10_4_978-1-60327-527-9">
                  <Emphasis Type="Bold">10.4a</Emphasis>
                </InternalRef>). The SBP-tag can bind to streptavidin, and can thus be bound to streptavidin supports. As biotin has a higher affinity for streptavidin, it releases the SBP-tag from the streptavidin. Similarly, the sc tag has a higher affinity for nitro-iodo-phenol (NIP) than for nitro-phenol (NP), and can thus be bound to NP-sepharose beads, and eluted with soluble NIP. Both of these affinity-tag based purification methods require expression of the tagged subunit, preferably in a cell line that lacks the corresponding endogenous subunit. While this requirement is indeed a drawback, these tags are useful for highly efficient purification of the TCR.</Para>
              <Section3 ID="Sec11" OutputMedium="Online">
                <Heading>Purification of the TCR Utilizing ζ-SBP</Heading>
                <Para TextBreak="No">
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Harvest 20 × 10<Superscript>6</Superscript> cells expressing TCRζ-SBP (Mζ-SBP) and wash once in PBS.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">For purification of ζ-SBP-containing protein complexes, lyse the cells in 1 ml ice-cold lysis buffer as in <Emphasis Type="Bold">Section 3.1</Emphasis>, steps 3–4.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Add streptavidin-coupled agarose or sepharose (approximately 7 µl) to the clarified supernatant, and allow binding of the TCR-SBP for 2–4 h rotating at 4°C.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Wash beads three times in BN-wash buffer.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Elute the TCR-SBP from the beads by incubation with 100 μl BN wash buffer containing 2 mM biotin for 20 min at 4°C. Resuspend occasionally with a pipette (<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Note 6</Emphasis>).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Centrifuge the beads briefly, and transfer the supernatant to a new tube.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">The TCR-containing eluate is now ready to be separated by BN-PAGE.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section3>
              <Section3 ID="Sec12" OutputMedium="Online">
                <Heading>Purification of the TCR Utilizing scTCRβ</Heading>
                <Para TextBreak="No">
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Harvest 20 × 10<Superscript>6</Superscript> of the 31.13scTCRβ cells. Lyse the cells as given before (<Emphasis Type="Bold">Section 3.1</Emphasis>).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">To purify the scTCR through the sc fragment of the anti-NIP antibody, allow the cleared lysate to bind to 5 μl NP-sepharose beads for 4 h.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Wash the beads as above, and then elute the TCR from the beads in 20 µl BN wash buffer containing 5 mM NIP-CAP. Resuspend the beads occasionally, and elute for 30 min (<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Note 6</Emphasis>).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">Pellet the beads, and transfer the eluate to a new chilled tube.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para TextBreak="No">The TCR-containing eluate is now ready to be separated by BN-PAGE.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section3>
            </Section2>
            <Section2 ID="Sec13" OutputMedium="Online">
              <Heading>Pouring and Running of the Blue-Native PAGE Gels</Heading>
              <Para TextBreak="No">BN-PAGE gels are polyacrylamide gradient gels to ensure better separation over a wide range of protein complexes size <CitationRef CitationID="CR9">(9)</CitationRef>. The high-percentage separating gel solution contains glycerol, so that it settles down due to its higher density and aids in the gradient formation. The gels are poured at room temperature, and pre-chilled before loading. The running of the gel is then completely performed at 4°C. A protocol to pour and run small (6 × 10 cm, 1 mm thick, e.g. Protean II Bio-Rad) gels is given <CitationRef CitationID="CR11">(11)</CitationRef>.<OrderedList>
                  <ListItem>
                    <ItemNumber>1.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">The set-up for the pouring of the gels is shown in <Emphasis Type="Bold">Fig.</Emphasis>
                        <InternalRef RefID="Fig10_5_978-1-60327-527-9">
                          <Emphasis Type="Bold">10.5</Emphasis>
                        </InternalRef>. Place the gradient mixer on the magnetic stirrer, and the magnet in the chamber closer to the exit. Attach the tubing as shown (<Emphasis Type="Bold">Fig.</Emphasis>
                        <InternalRef RefID="Fig10_5_978-1-60327-527-9">
                          <Emphasis Type="Bold">10.5</Emphasis>
                        </InternalRef>), and pass it through the peristaltic pump. At the other end, attach a syringe needle, and place the tip of the needle between the glass plates of the gel apparatus. Keep the connecting channel between the two chambers of the mixer closed (using the valve) as well as the out-flowing tubing (using the clamp).
<Figure Category="Standard" Float="Yes" ID="Fig10_5_978-1-60327-527-9">
                          <Caption Language="En">
                            <CaptionNumber>Fig. 10.5.</CaptionNumber>
                            <CaptionContent>
                              <SimplePara>Schematic representation of the set-up for the pouring of the native gradient gels.</SimplePara>
                              <SimplePara>The gradient mixer is placed on the magnetic stirrer with a magnet stir bar in the more proximal chamber. The tube from the gradient mixer is passed through a peristaltic pump, which controls the flow of the gel liquid into the gel apparatus. The high- and low-percentage gel mixtures should be poured into the indicated chambers of the gradient mixer. Once the gel mixtures are in the chambers, the stirrer is switched on, the channel between the chambers is opened by the valve, the clip is removed and the pump is switched on. The gel mixture is allowed to slowly enter between the glass plates of the gel apparatus (not shown). When all the liquid has entered the gel apparatus, the gel is overlaid with isopropanol and allowed to polymerize.</SimplePara>
                            </CaptionContent>
                          </Caption>
                          <MediaObject>
                            <ImageObject Color="BlackWhite" FileRef="MediaObjects/978-1-60327-527-9_10_Fig5_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Linedraw"/>
                          </MediaObject>
                        </Figure>
                      </Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>2.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Prepare the low- and high-percentage separating gel solutions, adding APS and TEMED immediately before use.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>3.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Pour the low- and high-percentage solutions into the corresponding chambers of the mixer. Switch on the magnetic stirrer and open the channel valve. Remove the clamp and switch on the peristaltic pump at a speed that allows the gel solution to fill in between the glass plates in 1–2 min. Ensure that liquid is flowing between the two chambers of the gradient mixture by putting gentle pressure on the side of the “low” chamber.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>4.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Allow all the solution to enter between the glass plates, always maintaining the needle tip above the liquid level. Overlay with isopropanol. Allow the gel to polymerize for at least 30 min at room temperature.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>5.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Remove the isopropanol, rinse with water, air-dry (<Emphasis Type="Italic">see</Emphasis>
                        <Emphasis Type="Bold">Note 7</Emphasis>).</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>6.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Pour the stacking gel and insert the combs as for a normal SDS Laemmli gel.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>7.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Allow the gel to polymerize for 10 min at room temperature, and for a further 20 min at 4°C. This helps to make the stacking gel slightly more solid, which aids in the removal of the comb.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>8.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Remove the comb slowly, moving it back and forth against the plates, so that air can enter into the wells. The upper gel is semi-solid, so this improves the quality of the wells. Maintain the gel at 4°C.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>9.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Rinse the wells with dH<Subscript>2</Subscript>O, and then load the prepared samples in the dry wells in a cold room. Load 10 µl of the marker protein mix.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>10.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Overlay the sample in each well with cold cathode buffer.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>11.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Fit the gel in the running apparatus; fill the inner chamber with cold cathode buffer, and the outer/lower chamber with cold anode buffer.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>12.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Allow the samples to enter the stacking gel at 20–50 V, after which the gel can either be run overnight at 20 V, or at 2 mA/cm<Superscript>2</Superscript> until the running front has reached the bottom of the gel. In the second case, the gel run takes between 3 and 4 h. The entire procedure is done in a cold room/ at 4°C. After the gel run, the gel will be completely blue, with a more intense blue running front.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>13.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Transfer the proteins from the BN-PAGE gel to a PVDF membrane using standard blotting procedures. The transfer buffer must contain 0.1% SDS for efficient subsequent immunoblotting (<Emphasis Type="Italic">see</Emphasis>
                        <Emphasis Type="Bold">Note 8</Emphasis>).</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>14.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">Silver or Coomassie staining are also possible.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>15.</ItemNumber>
                    <ItemContent>
                      <Para TextBreak="No">The individual lanes of the BN-PAGE gel can also be cut out and loaded on a two-dimensional SDS-PAGE. Incubating the gel strip in Laemmli buffer beforehand for 30 min ensures complete denaturing of the proteins (<Emphasis Type="Italic">see</Emphasis>
                        <Emphasis Type="Bold">Note</Emphasis>s <Emphasis Type="Bold">9 and 10</Emphasis>). After two-dimensional BN-/SDS-PAGE, normal Western blotting, silver or Coomassie staining can be done (<Emphasis Type="Italic">see</Emphasis>
                        <Emphasis Type="Bold">Fig.</Emphasis>
                        <InternalRef RefID="Fig10_3_978-1-60327-527-9">
                          <Emphasis Type="Bold">10.3c</Emphasis>
                        </InternalRef>).</Para>
                    </ItemContent>
                  </ListItem>
                </OrderedList>
              </Para>
            </Section2>
          </Section1>
          <Section1 ID="Sec14" OutputMedium="Online">
            <Heading>Notes</Heading>
            <Para TextBreak="No">
              <OrderedList>
                <ListItem>
                  <ItemNumber>1.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">We prepare acrylamide:bisacrylamide solution with the right ratio of 32:1 by mixing 17.66 ml Rotiphorese Gel 40 (40% acrylamide, Roth, Germany) that has an acrylamide:bisacrylamide ratio of 19:1 with 82.34 ml of Rotiphorese Gel 40 with a ratio of 37.5:1.</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>2.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Maintain all apparatus for the BN-PAGE SDS-free. Rinse only in dH<Subscript>2</Subscript>O to clean.</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>3.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Not all antibodies work for immunoblotting after BN-PAGE. This could be due to the bound Coomassie, which can only be partially removed by methanol from PVDF membranes, and not at all from nitrocellulose. Additionally, fluorescence detection of proteins on the membrane is not possible, because Coomassie is highly fluorescent (in both red and green channels).</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>4.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Of the marker proteins listed here, only ferritin is visible during the gel run due to its brown colour. Since the monovalent TCR is normally found just below the height of the first ferritin band, we routinely use only this protein as a marker in our gels.</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>5.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">If total membranes are prepared, there is always some amount of precipitation of Coomassie and proteins in the well, and also at the interface between the stacking and separating gel. If, however, there is excessive precipitation, so that proteins are not able to enter the well (seen as streaks in the gel where the blue dye does not enter), then a second ultra centrifugation step after lysis of the membrane pellets may be necessary.</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>6.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">To increase TCR recovery during elution from the affinity columns/beads from small cell numbers (<Emphasis Type="Bold">Sections 3.1 and 3.3</Emphasis>), two rounds of elution can be performed serially using the same beads. Subsequently, the eluates are pooled.</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>7.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">After the lower separating part of the BN-PAGE gel has been poured, it can be overlaid with 1× BN-gel buffer, and can then be stored for up to half a year in a humid environment at 4°C. We routinely pour 12–13 gels using the Bio-Rad multicaster system, and store the gels for use as required.</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>8.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">Standard procedures are used for transferring the proteins from the native gels to PVDF or nitrocellulose membranes. Inclusion of SDS in the transfer buffer can help for immunoblotting of the TCR with antibodies that recognize the denatured proteins. Conversely, native transfer conditions (without SDS) may aid detection by antibodies that recognize the native proteins (<Emphasis Type="Italic">see also Note 3</Emphasis>).</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>9.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">If performing a second dimension SDS-PAGE, it helps to put tape (i.e. Cello tape or Tesafilm) on the spacers of the SDS-PAGE gel apparatus to slightly increase the thickness of the gel. Then the BN gel slice can easily slide in between the two glass plates, but is still held relatively tightly in place.</Para>
                  </ItemContent>
                </ListItem>
                <ListItem>
                  <ItemNumber>10.</ItemNumber>
                  <ItemContent>
                    <Para TextBreak="No">If performing a second dimension SDS-PAGE, boiling of the gel slice in Laemmli buffer is normally not necessary for the TCR; however, if recovery in the second dimension gel is not very good, briefly boiling the gel slice (20 s) in SDS-containing buffer may help.</Para>
                  </ItemContent>
                </ListItem>
              </OrderedList>
            </Para>
          </Section1>
        </Body>
        <BodyRef FileRef="BodyRef/PDF/978-1-60327-527-9_Chapter_10.pdf" OutputMedium="All" PDFType="Typeset" TargetType="OnlinePDF"/>
        <ChapterBackmatter>
          <Bibliography ID="Bib1">
            <Heading>References</Heading>
            <Citation ID="CR1">
              <CitationNumber>1.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>JJ.</Initials>
                  <FamilyName>Boniface</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>JD.</Initials>
                  <FamilyName>Rabinowitz</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>C.</Initials>
                  <FamilyName>Wulfing</FamilyName>
                </BibAuthorName>
                <Etal/>
                <Year>1998</Year>
                <ArticleTitle Language="En">Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected]</ArticleTitle>
                <JournalTitle>Immunity</JournalTitle>
                <VolumeID>9</VolumeID>
                <FirstPage>459</FirstPage>
                <LastPage>66</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DyaK1cXnsVymurk%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1016/S1074-7613(00)80629-9</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>9806632</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Boniface JJ, Rabinowitz JD, Wulfing C, et al. Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected]. Immunity 1998;9:459–66.</BibUnstructured>
            </Citation>
            <Citation ID="CR2">
              <CitationNumber>2.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>JR.</Initials>
                  <FamilyName>Cochran</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>TO.</Initials>
                  <FamilyName>Cameron</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>LJ.</Initials>
                  <FamilyName>Stern</FamilyName>
                </BibAuthorName>
                <Year>2000</Year>
                <ArticleTitle Language="En">The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers</ArticleTitle>
                <JournalTitle>Immunity</JournalTitle>
                <VolumeID>12</VolumeID>
                <FirstPage>241</FirstPage>
                <LastPage>50</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DC%2BD3cXisVWku78%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1016/S1074-7613(00)80177-6</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>10755611</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Cochran JR, Cameron TO, Stern LJ. The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers. Immunity 2000;12:241–50.</BibUnstructured>
            </Citation>
            <Citation ID="CR3">
              <CitationNumber>3.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>D.</Initials>
                  <FamilyName>Gil</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>WW.</Initials>
                  <FamilyName>Schamel</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>M.</Initials>
                  <FamilyName>Montoya</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>F.</Initials>
                  <FamilyName>Sanchez-Madrid</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>B.</Initials>
                  <FamilyName>Alarcon</FamilyName>
                </BibAuthorName>
                <Year>2002</Year>
                <ArticleTitle Language="En">Recruitment of Nck by CD3 epsilon reveals a ligand-induced conformational change essential for T cell receptor signaling and synapse formation</ArticleTitle>
                <JournalTitle>Cell</JournalTitle>
                <VolumeID>109</VolumeID>
                <FirstPage>901</FirstPage>
                <LastPage>12</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DC%2BD38Xlt1eiu70%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1016/S0092-8674(02)00799-7</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>12110186</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Gil D, Schamel WW, Montoya M, Sanchez-Madrid F, Alarcon B. Recruitment of Nck by CD3 epsilon reveals a ligand-induced conformational change essential for T cell receptor signaling and synapse formation. Cell 2002;109:901–12.</BibUnstructured>
            </Citation>
            <Citation ID="CR4">
              <CitationNumber>4.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>S.</Initials>
                  <FamilyName>Minguet</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>M.</Initials>
                  <FamilyName>Swamy</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>B.</Initials>
                  <FamilyName>Alarcon</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>IF.</Initials>
                  <FamilyName>Luescher</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>WW.</Initials>
                  <FamilyName>Schamel</FamilyName>
                </BibAuthorName>
                <Year>2007</Year>
                <ArticleTitle Language="En">Full activation of the T cell receptor requires both clustering and conformational changes at CD3</ArticleTitle>
                <JournalTitle>Immunity</JournalTitle>
                <VolumeID>26</VolumeID>
                <FirstPage>43</FirstPage>
                <LastPage>54</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DC%2BD2sXhsFKitL4%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1016/j.immuni.2006.10.019</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>17188005</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Minguet S, Swamy M, Alarcon B, Luescher IF, Schamel WW. Full activation of the T cell receptor requires both clustering and conformational changes at CD3. Immunity 2007;26:43–54.</BibUnstructured>
            </Citation>
            <Citation ID="CR5">
              <CitationNumber>5.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>K.</Initials>
                  <FamilyName>Choudhuri</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>A.</Initials>
                  <FamilyName>Kearney</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>TR.</Initials>
                  <FamilyName>Bakker</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>PA.</Initials>
                  <FamilyName>Merwe</FamilyName>
                  <Particle>van der</Particle>
                </BibAuthorName>
                <Year>2005</Year>
                <ArticleTitle Language="En">Immunology: how do T cells recognize antigen?</ArticleTitle>
                <JournalTitle>Curr Biol</JournalTitle>
                <VolumeID>15</VolumeID>
                <FirstPage>R382</FirstPage>
                <LastPage>5</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DC%2BD2MXks1Gjtbk%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1016/j.cub.2005.05.001</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>15916940</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Choudhuri K, Kearney A, Bakker TR, van der Merwe PA. Immunology: how do T cells recognize antigen? Curr Biol 2005;15:R382–5.</BibUnstructured>
            </Citation>
            <Citation ID="CR6">
              <CitationNumber>6.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>JA.</Initials>
                  <FamilyName>Punt</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>JL.</Initials>
                  <FamilyName>Roberts</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>KP.</Initials>
                  <FamilyName>Kearse</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>A.</Initials>
                  <FamilyName>Singer</FamilyName>
                </BibAuthorName>
                <Year>1994</Year>
                <ArticleTitle Language="En">Stoichiometry of the T cell antigen receptor (TCR) complex: each TCR/CD3 complex contains one TCRa, one TCRb and two CD3e chains</ArticleTitle>
                <JournalTitle>J Exp Med</JournalTitle>
                <VolumeID>180</VolumeID>
                <FirstPage>587</FirstPage>
                <LastPage>93</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DyaK2cXltVKiurg%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1084/jem.180.2.587</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>8046335</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Punt JA, Roberts JL, Kearse KP, Singer A. Stoichiometry of the T cell antigen receptor (TCR) complex: each TCR/CD3 complex contains one TCRa, one TCRb and two CD3e chains. J Exp Med 1994;180:587–93.</BibUnstructured>
            </Citation>
            <Citation ID="CR7">
              <CitationNumber>7.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>G.</Initials>
                  <FamilyName>Fernandez-Miguel</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>B.</Initials>
                  <FamilyName>Alarcon</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>A.</Initials>
                  <FamilyName>Iglesias</FamilyName>
                </BibAuthorName>
                <Etal/>
                <Year>1999</Year>
                <ArticleTitle Language="En">Multivalent structure of an alphabetaT cell receptor</ArticleTitle>
                <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                <VolumeID>96</VolumeID>
                <FirstPage>1547</FirstPage>
                <LastPage>52</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DyaK1MXhsFSqsrg%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1073/pnas.96.4.1547</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>9990061</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Fernandez-Miguel G, Alarcon B, Iglesias A, et al. Multivalent structure of an alphabetaT cell receptor. Proc Natl Acad Sci USA 1999;96:1547–52.</BibUnstructured>
            </Citation>
            <Citation ID="CR8">
              <CitationNumber>8.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>H.</Initials>
                  <FamilyName>Schägger</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>WA.</Initials>
                  <FamilyName>Cramer</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>G.</Initials>
                  <FamilyName>Jagow</FamilyName>
                  <Particle>von</Particle>
                </BibAuthorName>
                <Year>1994</Year>
                <ArticleTitle Language="En">Analysis of molecular masses and oligomeric states of protein complexes by blue native electrophoresis and isolation of membrane protein complexes by two-dimensional native electrophoresis</ArticleTitle>
                <JournalTitle>Anal Biochem</JournalTitle>
                <VolumeID>217</VolumeID>
                <FirstPage>220</FirstPage>
                <LastPage>30</LastPage>
                <Occurrence Type="DOI">
                  <Handle>10.1006/abio.1994.1112</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>8203750</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Schägger H, Cramer WA, von Jagow G. Analysis of molecular masses and oligomeric states of protein complexes by blue native electrophoresis and isolation of membrane protein complexes by two-dimensional native electrophoresis. Anal Biochem 1994; 217:220–30.</BibUnstructured>
            </Citation>
            <Citation ID="CR9">
              <CitationNumber>9.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>H.</Initials>
                  <FamilyName>Schägger</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>G.</Initials>
                  <FamilyName>Jagow</FamilyName>
                  <Particle>von</Particle>
                </BibAuthorName>
                <Year>1991</Year>
                <ArticleTitle Language="En">Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form</ArticleTitle>
                <JournalTitle>Anal Biochem</JournalTitle>
                <VolumeID>199</VolumeID>
                <FirstPage>223</FirstPage>
                <LastPage>31</LastPage>
                <Occurrence Type="DOI">
                  <Handle>10.1016/0003-2697(91)90094-A</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>1812789</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Schägger H, von Jagow G. Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem 1991;199:223–31.</BibUnstructured>
            </Citation>
            <Citation ID="CR10">
              <CitationNumber>10.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>M.</Initials>
                  <FamilyName>Swamy</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>Y.</Initials>
                  <FamilyName>Kulathu</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>S.</Initials>
                  <FamilyName>Ernst</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>M.</Initials>
                  <FamilyName>Reth</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>WW.</Initials>
                  <FamilyName>Schamel</FamilyName>
                </BibAuthorName>
                <Year>2006</Year>
                <ArticleTitle Language="En">Two dimensional Blue Native-/SDS-PAGE analysis of SLP family adaptor protein complexes</ArticleTitle>
                <JournalTitle>Immunol Lett</JournalTitle>
                <VolumeID>104</VolumeID>
                <FirstPage>131</FirstPage>
                <LastPage>7</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DC%2BD28XitValtr4%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1016/j.imlet.2005.11.004</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>16356554</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Swamy M, Kulathu Y, Ernst S, Reth M, Schamel WW. Two dimensional Blue Native-/SDS-PAGE analysis of SLP family adaptor protein complexes. Immunol Lett 2006; 104:131–7.</BibUnstructured>
            </Citation>
            <Citation ID="CR11">
              <CitationNumber>11.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>M.</Initials>
                  <FamilyName>Swamy</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>GM.</Initials>
                  <FamilyName>Siegers</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>S.</Initials>
                  <FamilyName>Minguet</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>B.</Initials>
                  <FamilyName>Wollscheid</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>WW.</Initials>
                  <FamilyName>Schamel</FamilyName>
                </BibAuthorName>
                <Year>2006</Year>
                <ArticleTitle Language="En">Blue native polyacrylamide gel electrophoresis (BN-PAGE) for the identification and analysis of multiprotein complexes</ArticleTitle>
                <JournalTitle>Sci STKE</JournalTitle>
                <VolumeID>2006</VolumeID>
                <FirstPage>l4</FirstPage>
                <Occurrence Type="DOI">
                  <Handle>10.1126/stke.3452006pl4</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Swamy M, Siegers GM, Minguet S, Wollscheid B, Schamel WW. Blue native polyacrylamide gel electrophoresis (BN-PAGE) for the identification and analysis of multiprotein complexes. Sci STKE 2006;2006:pl4.</BibUnstructured>
            </Citation>
            <Citation ID="CR12">
              <CitationNumber>12.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>WW.</Initials>
                  <FamilyName>Schamel</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>I.</Initials>
                  <FamilyName>Arechaga</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>RM.</Initials>
                  <FamilyName>Risueno</FamilyName>
                </BibAuthorName>
                <Etal/>
                <Year>2005</Year>
                <ArticleTitle Language="En">Coexistence of multivalent and monovalent TCRs explains high sensitivity and wide range of response</ArticleTitle>
                <JournalTitle>J Exp Med</JournalTitle>
                <VolumeID>202</VolumeID>
                <FirstPage>493</FirstPage>
                <LastPage>503</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DC%2BD2MXosVarsr0%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1084/jem.20042155</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>16087711</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Schamel WW, Arechaga I, Risueno RM, et al. Coexistence of multivalent and monovalent TCRs explains high sensitivity and wide range of response. J Exp Med 2005;202: 493–503.</BibUnstructured>
            </Citation>
            <Citation ID="CR13">
              <CitationNumber>13.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>B.</Initials>
                  <FamilyName>Alarcon</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>M.</Initials>
                  <FamilyName>Swamy</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>HM.</Initials>
                  <FamilyName>Santen</FamilyName>
                  <Particle>van</Particle>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>WW.</Initials>
                  <FamilyName>Schamel</FamilyName>
                </BibAuthorName>
                <Year>2006</Year>
                <ArticleTitle Language="En">T-cell antigen-receptor stoichiometry: pre-clustering for sensitivity</ArticleTitle>
                <JournalTitle>EMBO Rep</JournalTitle>
                <VolumeID>7</VolumeID>
                <FirstPage>490</FirstPage>
                <LastPage>5</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DC%2BD28XktVWgsL8%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1038/sj.embor.7400682</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>16670682</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Alarcon B, Swamy M, van Santen HM, Schamel WW. T-cell antigen-receptor stoichiometry: pre-clustering for sensitivity. EMBO Rep 2006;7:490–5.</BibUnstructured>
            </Citation>
            <Citation ID="CR14">
              <CitationNumber>14.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>AD.</Initials>
                  <FamilyName>Keefe</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>DS.</Initials>
                  <FamilyName>Wilson</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>B.</Initials>
                  <FamilyName>Seelig</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>JW.</Initials>
                  <FamilyName>Szostak</FamilyName>
                </BibAuthorName>
                <Year>2001</Year>
                <ArticleTitle Language="En">One-step purification of recombinant proteins using a nanomolar-affinity streptavidin-binding peptide, the SBP-Tag</ArticleTitle>
                <JournalTitle>Protein Expr Purif</JournalTitle>
                <VolumeID>23</VolumeID>
                <FirstPage>440</FirstPage>
                <LastPage>6</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DC%2BD3MXosFGnsr8%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1006/prep.2001.1515</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>11722181</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Keefe AD, Wilson DS, Seelig B, Szostak JW. One-step purification of recombinant proteins using a nanomolar-affinity streptavidin-binding peptide, the SBP-Tag. Protein Expr Purif 2001;23:440–6.</BibUnstructured>
            </Citation>
            <Citation ID="CR15">
              <CitationNumber>15.</CitationNumber>
              <BibArticle>
                <BibAuthorName>
                  <Initials>WW.</Initials>
                  <FamilyName>Schamel</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>S.</Initials>
                  <FamilyName>Kuppig</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>B.</Initials>
                  <FamilyName>Becker</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>K.</Initials>
                  <FamilyName>Gimborn</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>HP.</Initials>
                  <FamilyName>Hauri</FamilyName>
                </BibAuthorName>
                <BibAuthorName>
                  <Initials>M.</Initials>
                  <FamilyName>Reth</FamilyName>
                </BibAuthorName>
                <Year>2003</Year>
                <ArticleTitle Language="En">A high molecular weight complex of BAP29/BAP31 is involved in the retention of membrane-bound IgD in the endoplasmic reticulum</ArticleTitle>
                <JournalTitle>Proc Natl Acad Sci</JournalTitle>
                <VolumeID>100</VolumeID>
                <FirstPage>9861</FirstPage>
                <LastPage>6</LastPage>
                <Occurrence Type="COI">
                  <Handle>1:CAS:528:DC%2BD3sXmvVejtbY%3D</Handle>
                </Occurrence>
                <Occurrence Type="DOI">
                  <Handle>10.1073/pnas.1633363100</Handle>
                </Occurrence>
                <Occurrence Type="PID">
                  <Handle>12886015</Handle>
                </Occurrence>
              </BibArticle>
              <BibUnstructured>Schamel WW, Kuppig S, Becker B, Gimborn K, Hauri HP, Reth M. A high molecular weight complex of BAP29/BAP31 is involved in the retention of membrane-bound IgD in the endoplasmic reticulum. Proc Natl Acad Sci 2003;100:9861–6.</BibUnstructured>
            </Citation>
          </Bibliography>
        </ChapterBackmatter>
      </Chapter>
    </Book>
  </Series>
</Publisher>
